CTOs on the Move

HMC HealthWorks

www.hmchealthworks.com

 
Say goodbye to a blanket approach to healthcare. We personalize each plan sponsor`s needs toward improving the health and quality of life of participants. The result? Reduced healthcare spend and a healthier population. HMC`s 40 years of clinically-based protocols produces an impact that engages, empowers and delivers.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Lebanon Nursing and Rehab

Lebanon Nursing and Rehab is a Lebanon, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Crofton Convalescent Ctr

Crofton Convalescent Ctr is a Crofton, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MD Anderson Cancer Center

MD Anderson has built a worldwide reputation for excellence in cancer patient care, research, education and prevention. We couldn`t have done it without our top-notch faculty and staff, or the generous spirit of volunteers and community members who donate everything from free time to pints of blood to help us in our mission to end cancer. Our various departments work as a team to deliver multidisciplinary cancer care, a concept pioneered by MD Anderson.

Abington Memorial Hospital

Abington Memorial Hospital, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Abington Memorial Hospital, Inc. is based in Abington, PA. You can find more information on Abington Memorial Hospital, Inc. at www.amh.org

Voyager Therapeutics

Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.